Enveric Biosciences Stock Performance
| ENVB Stock | USD 1.74 0.01 0.58% |
The firm shows a Beta (market volatility) of 1.52, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Enveric Biosciences will likely underperform. At this point, Enveric Biosciences has a negative expected return of -0.59%. Please make sure to confirm Enveric Biosciences' kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Enveric Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:15 | Dividend Date 2019-11-25 | Ex Dividend Date 2008-04-23 | Last Split Date 2025-01-29 |
1 | Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During J.P. Morgan Week 2025 | 01/06/2025 |
2 | Enveric Biosciences Announces Pricing of 5 Million Public Offering | 01/31/2025 |
3 | Enveric Biosciences Announces Closing of 5 Million Public Offering | 02/03/2025 |
4 | ENVB stock touches 52-week low at 1.51 amid market challenges - MSN | 02/11/2025 |
5 | EXCLUSIVE Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD | 02/25/2025 |
6 | Enveric Biosciences CEO Issues Letter to Shareholders | 02/27/2025 |
7 | Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark | 03/06/2025 |
8 | Acquisition by Pasqualone Frank of 47733 shares of Enveric Biosciences subject to Rule 16b-3 | 03/12/2025 |
9 | Enveric Biosciences Participating in BIO-Europe Spring | 03/17/2025 |
| Begin Period Cash Flow | 17.7 M |
Enveric |
Enveric Biosciences Relative Risk vs. Return Landscape
If you would invest 465.00 in Enveric Biosciences on December 23, 2024 and sell it today you would lose (291.00) from holding Enveric Biosciences or give up 62.58% of portfolio value over 90 days. Enveric Biosciences is currently does not generate positive expected returns and assumes 15.7082% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Enveric, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Enveric Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enveric Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Enveric Biosciences, and traders can use it to determine the average amount a Enveric Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0378
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ENVB |
Estimated Market Risk
| 15.71 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.59 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Enveric Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enveric Biosciences by adding Enveric Biosciences to a well-diversified portfolio.
Enveric Biosciences Fundamentals Growth
Enveric Stock prices reflect investors' perceptions of the future prospects and financial health of Enveric Biosciences, and Enveric Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Enveric Stock performance.
| Return On Equity | -3.09 | ||||
| Return On Asset | -0.97 | ||||
| Current Valuation | (3.67 M) | ||||
| Shares Outstanding | 1.92 M | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 0.08 X | ||||
| Gross Profit | 8.15 M | ||||
| EBITDA | (16.85 M) | ||||
| Net Income | (17.29 M) | ||||
| Cash And Equivalents | 18.01 M | ||||
| Cash Per Share | 11.44 X | ||||
| Total Debt | 2.34 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.33 X | ||||
| Book Value Per Share | 6.59 X | ||||
| Cash Flow From Operations | (14.09 M) | ||||
| Earnings Per Share | (34.31) X | ||||
| Market Capitalization | 3.5 M | ||||
| Total Asset | 4.3 M | ||||
| Retained Earnings | (96.5 M) | ||||
| Working Capital | 1.24 M | ||||
About Enveric Biosciences Performance
By analyzing Enveric Biosciences' fundamental ratios, stakeholders can gain valuable insights into Enveric Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Enveric Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Enveric Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (86.74) | (82.40) | |
| Return On Tangible Assets | 0.00 | (0.01) | |
| Return On Capital Employed | (9.67) | (9.19) | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Enveric Biosciences performance evaluation
Checking the ongoing alerts about Enveric Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Enveric Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Enveric Biosciences generated a negative expected return over the last 90 days | |
| Enveric Biosciences has high historical volatility and very poor performance | |
| Enveric Biosciences may become a speculative penny stock | |
| Enveric Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (17.29 M) with profit before overhead, payroll, taxes, and interest of 8.15 M. | |
| Enveric Biosciences currently holds about 18.01 M in cash with (14.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Enveric Biosciences has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Enveric Biosciences Participating in BIO-Europe Spring |
- Analyzing Enveric Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Enveric Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Enveric Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Enveric Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Enveric Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Enveric Biosciences' stock. These opinions can provide insight into Enveric Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Enveric Stock analysis
When running Enveric Biosciences' price analysis, check to measure Enveric Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enveric Biosciences is operating at the current time. Most of Enveric Biosciences' value examination focuses on studying past and present price action to predict the probability of Enveric Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enveric Biosciences' price. Additionally, you may evaluate how the addition of Enveric Biosciences to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |